Medical Program: What is the Role of KRAS Testing in Therapeutic Decision Making for mCRC?

What is the Role of KRAS Testing in Therapeutic Decision Making for mCRC?

What is the Role of KRAS Testing in Therapeutic Decision Making for mCRC?
RestartResume
Not sure which of your metastatic colorectal cancer patients would benefit from anti-EGFR drugs? That’s where KRAS testing comes in.
  • Overview

    Performing KRAS testing is an essential step clinicians need to take to determine which therapeutic option is best. In fact, skipping this step can actually be detrimental to patients. Here to talk about the important role of KRAS testing in metastatic colorectal cancer is Dr. Richard Kim, Medical Oncologist at Moffitt Cancer Center.

    Conversations on Colorectal Cancer is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Facebook Comments

NEW FEATURES:

Register

Join the Global Oncology Academy of learners.
Registration is free and easy.

Register Now